>Marché des dispositifs médicaux implantables actifs en Amérique du Nord, par produit (dispositifs de thérapie de resynchronisation cardiaque (CRT-D), défibrillateurs cardioverteurs implantables, stimulateurs cardiaques implantables, implants oculaires, neurostimulateurs, dispositifs auditifs implantables actifs, dispositifs d'assistance ventriculaire, moniteurs cardiaques implantables/enregistreurs de boucle insérables, curiethérapie, moniteurs de glycémie implantables, implants de pied tombant, implants d'épaule, pompes à perfusion implantables et accessoires implantables), type de chirurgie (méthodes chirurgicales traditionnelles et chirurgie mini-invasive), procédure (neurovasculaire, cardiovasculaire, auditive et autres), utilisateur final (hôpitaux, cliniques spécialisées, centres de chirurgie ambulatoire, cliniques), pays (États-Unis, Canada, Mexique) Tendances et prévisions de l'industrie jusqu'en 2028
Analyse et perspectives du marché : Marché actif des dispositifs médicaux implantables en Amérique du Nord
Le marché nord-américain des dispositifs médicaux implantables actifs devrait connaître une croissance significative au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché croît avec un TCAC de 7,9 % au cours de la période de prévision de 2021 à 2028 et devrait atteindre 12 665,68 millions USD d'ici 2028. L'augmentation des activités de R&D dans le secteur de la santé et l'augmentation des dépenses de santé sont les principaux moteurs de la croissance du marché au cours de la période de prévision. L'augmentation du financement et des investissements gouvernementaux a donné aux entreprises l'occasion de lancer davantage de produits. Cependant, le coût élevé et le rappel des produits des dispositifs implantables constituent un défi majeur pour le marché.
Les dispositifs médicaux implantables actifs sont des dispositifs motorisés qui sont insérés dans le corps d’un patient par une intervention chirurgicale et sont destinés à rester dans le corps du patient après l’intervention.
Les progrès technologiques croissants stimulent la croissance du marché nord-américain des dispositifs médicaux implantables actifs. Les investissements croissants dans les activités de développement de nouveaux produits dans les principales régions géographiques devraient stimuler la demande de dispositifs médicaux implantables actifs dans les années à venir. Alors que le coût et les effets nocifs du traitement freinent la croissance du marché.
Le rapport sur le marché des dispositifs médicaux implantables actifs en Amérique du Nord fournit des détails sur la part de marché, les nouveaux développements et l'analyse du pipeline de produits, l'impact des acteurs du marché national et local, analyse les opportunités en termes de poches de revenus émergentes, de changements dans la réglementation du marché, d'approbations de produits, de décisions stratégiques, de lancements de produits, d'expansions géographiques et d'innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché, contactez-nous pour un briefing d'analyste, notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.
Portée et taille du marché des dispositifs médicaux implantables actifs en Amérique du Nord
North America Active medical implantable devices market is segmented on the basis of product, surgery type, procedure, and end users. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product, the North America active medical implantable devices market is segmented into Cardiac Resynchronization Therapy Devices (CRT-D), implantable cardioverter defibrillators, implantable cardiac pacemakers, eye implants, neurostimulators, active implantable hearing devices, ventricular assist devices, implantable heart monitors/ insertable loop recorders, brachytheraphy, implantable glucose monitors, dropped foot implants, shoulder implants, implantable infusion pumps and implantable accessories. In 2021, Cardiac Resynchronization Therapy Devices (CRT-D) segment is expected to dominate the market owing to increase in the demand for implantable devices stoked by their efficient results.
- On the basis of surgery type the North America active medical implantable devices market is segmented into traditional surgical methods and minimally invasive surgery. In 2021, traditional surgical methods segment is expected to dominate the market as it have reasonable cost and expense of the treatment.
- On the basis of procedure, the North America active medical implantable devices market is segmented into neurovascular, cardiovascular, hearing and others. In 2021, cardiovascular is expected to dominate the market with the increase in cardiovascular disease.
- On the basis of end-users, the North America active medical implantable devices market is segmented into hospitals, specialty clinics, ambulatory surgical centers and clinics. In 2021, hospital segment is expected to dominate the market due growing demand of active medical implantable devices
North America Active Medical Implantable Devices Market Country Level Analysis
The North America active medical implantable devices market is analyzed and market size information is provided on the basis of product, surgery type, procedure, end users.
The countries covered in the active medical implantable devices market report are the U.S., Canada, and Mexico.
Active medical implantable devices segment in North America region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of increasing research development for enhancing the product quality. The U.S is leading the growth of the North America active medical implantable devices market and cardiovascular segment is dominating in this country due to increasing prevalence of diseases in the country.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Increase in advancement and technology for new product development are boosting the market growth of active medical implantable devices growth
North America active medical implantable devices market also provides you with detailed market analysis for every country growth in active medical implantable devices industry with active medical implantable devices drugs sales, impact of advancement in the active medical implantable devices technology and changes in regulatory scenarios with their support for the market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Active Medical Implantable Devices Market Share Analysis
Active medical implantable devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to active medical implantable devices market.
The major companies which are dealing in the North America active medical implantable devices market are NeuroPace, Inc., Axonics, Inc., Stimwave LLC, NEVRO CORP, Second Sight, BIOTRONIK, ABIOMED, Boston Scientific Corporation, Medtronic, Abbott, Eckert & Ziegler., Sonova, Zhejiang Nurotron Biotechnology Co., Ltd, Demant A/S, Cochlear Ltd, Microson, Oticon Medical, Nano Retina, GluSense, MED-EL Medical Electronics among others.
Several product launches and agreements are also initiated by the companies worldwide, which are also accelerating the growth of the active medical implantable devices market.
For instance,
- In March 2021, Medline industries, Inc announced that they have been awarded a prime vendor contract to serve as the exclusive supply vendor for Windsor Lane Health Care, an Ohio-based long-term care facility which has increased its supply chain in United States.
- En janvier 2020, Medline Industries, Inc. a annoncé l'acquisition de Médi-Sélect, un distributeur de fournitures médicales et dentaires basé à Québec, pour rejoindre ses opérations Medline Canada, ce qui a augmenté son réseau de distribution et de chaîne d'approvisionnement.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET APPLICATION COVERAGE GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 INDUSTRY INSIGHTS
5 REGULATORY ANALYSIS
5.1 REGULATION IN EUROPE
5.2 REGULATION IN U.S.
5.3 REGULATION IN CANADA
5.4 REGULATION IN CHINA
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 TECHNOLOGICAL ADVANCEMENT
6.1.2 INCREASING BURDEN OF CARDIOVASCULAR DISEASES, NEUROLOGICAL DISORDERS AND HEARING DISORDERS
6.1.3 INCREASING FDA APPROVAL
6.1.4 RISING AWARENESS FOR MEDICAL IMPLANTS
6.2 RESTRAINTS
6.2.1 HIGH COST OF MEDICAL IMPLANTS
6.2.2 INCREASING RISK OF DEVELOPING INFECTION AND OTHER COMPLICATIONS
6.3 OPPORTUNITIES
6.3.1 INCREASE IN DEMAND FOR MINIMALLY INVASIVE SURGERIES
6.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
6.3.3 INCREASE IN THE GERIATRIC POPULATION
6.3.4 RISING HEALTHCARE INFRASTRUCTURE
6.4 CHALLENGES
6.4.1 INCREASING PRODUCT RECALL
6.4.2 SUPPLY CHAIN DISRUPTION DUT TO COVID-19 PANDEMIC OUTBREAK
7 IMPACT OF COVID-19
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY
7.4 STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS
7.5 CONCLUSION
8 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 CARDIAC RESYNCHRONIZATION THERAPY DEVICES (CRT-D)
8.3 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
8.3.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
8.3.1.1 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
8.3.1.2 BIVENTRICULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS)/ CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS (CRT-DS)
8.3.1.3 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
8.3.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
8.4 IMPLANTABLE CARDIAC PACEMAKERS
8.4.1 DUAL CHAMBER PACEMAKERS
8.4.2 BIVENTRICULAR PACEMAKERS
8.4.3 SINGLE CHAMBER PACEMAKERS
8.5 EYE IMPLANTS
8.6 NEUROSTIMULATORS
8.6.1 SPINAL CORD STIMULATORS
8.6.2 DEEP BRAIN STIMULATORS
8.6.3 BLADDER STIMULATORS
8.6.4 GASTRIC NERVE STIMULATORS
8.6.5 SACRAL NERVE STIMULATORS
8.6.6 LIMB FUNCTION STIMULATORS
8.6.7 VAGUS STIMULATORS
8.6.8 OTHERS
8.7 ACTIVE IMPLANTABLE HEARING DEVICES
8.8 VENTRICULAR ASSIST DEVICES
8.9 IMPLANTABLE HEART MONITORS/ INSERTABLE LOOP RECORDERS
8.1 BRACHYTHERAPY
8.11 IMPLANTABLE GLUCOSE MONITORS
8.12 DROPPED FOOT IMPLANTS
8.13 SHOULDER IMPLANTS
8.14 IMPLANTABLE INFUSION PUMPS
8.15 IMPLANTABLE ACCESSORIES
8.15.1 LEAD
8.15.2 ELECTRODES
8.15.3 ADAPTORS
8.15.4 OTHERS
9 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE
9.1 OVERVIEW
9.2 TRADITIONAL SURGICAL METHODS
9.3 MINIMALLY INVASIVE SURGERY
10 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE
10.1 OVERVIEW
10.2 CARDIOVASCULAR
10.3 NEUROLOGICAL
10.4 HEARING
10.5 OTHERS
11 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 AMBULATORY SURGICAL CENTERS
11.4 SPECIALIZED CLINICS
11.5 CLINICS
12 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.2 CANADA
12.1.3 MEXICO
13 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
14 COMPANY PROFILE
14.1 MEDTRONIC
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 ABBOTT
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 BOSTON SCIENTIFIC CORPORATION
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 COCHLEAR LTD
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENT
14.5 ABIOMED
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 AXONICS, INC.
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENTS
14.7 BIOTRONIK SE & CO. KG
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENTS
14.8 DEMANT A/S
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENT
14.9 ECKERT & ZIEGLER.
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT DEVELOPMENTS
14.1 GLUSENSE
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 MED-EL MEDICAL ELECTRONICS
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 MICROSON
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENTS
14.13 NANO RETINA
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 NEUROPACE, INC.
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT DEVELOPMENT
14.15 NEVRO CORP.
14.15.1 COMPANY SNAPSHOT
14.15.2 REVENUE ANALYSIS
14.15.3 PRODUCT PORTFOLIO
14.15.4 RECENT DEVELOPMENTS
14.15.5 RECENT DEVELOPMENTS
14.16 OTICON MEDICAL
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
14.17 SECOND SIGHT
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENT
14.18 SONOVA
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENTS
14.19 STIMWAVE LLC
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
14.2 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
Liste des tableaux
TABLE 1 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 2 NORTH AMERICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES (CRT-D) IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA EYE IMPLANTS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA NEUROSTIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA NEUROSTIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA ACTIVE IMPLANTABLE HEARING DEVICES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA VENTRICULAR ASSIST DEVICES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA IMPLANTABLE HEART MONITORS/ INSERTABLE LOOP RECORDERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA BRACHYTHERAPY IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA IMPLANTABLE GLUCOSE MONITORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA DROPPED FOOT IMPLANTS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA SHOULDER IMPLANTS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA IMPLANTABLE INFUSION PUMPS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA TRADITIONAL SURGICAL METHODS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA MINIMALLY INVASIVE SURGERY IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA CARDIOVASCULAR IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA NEUROLOGICAL IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA HEARING IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA OTHERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA HOSPITALS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA SPECIALIZED CLINICS IN BREAST RECONSTRUCTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA CLINICS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 43 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 U.S. ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 45 U.S. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 46 U.S. TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 47 U.S. IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 48 U.S. NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 49 U.S. IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 50 U.S. ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)
TABLE 51 U.S. ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 52 U.S. ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 53 CANADA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 54 CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 55 CANADA TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 56 CANADA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 57 CANADA NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 58 CANADA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 59 CANADA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)
TABLE 60 CANADA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 61 CANADA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 62 MEXICO ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 63 MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 64 MEXICO TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 65 MEXICO IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 66 MEXICO NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 67 MEXICO IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 68 MEXICO ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)
TABLE 69 MEXICO ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 70 MEXICO ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
Liste des figures
FIGURE 1 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 SURGERY TYPE LIFELINE CURVE
FIGURE 7 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: SEGMENTATION
FIGURE 12 THE INCREASE IN DEMAND FOR ACTIVE MEDICAL IMPLANTABLE DEVICES EXPECTED TO DRIVE THE NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 CARDIOVASCULAR SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET IN 2021 & 2028
FIGURE 14 NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET
FIGURE 16 AGING POPULATION IN THE WORLD (IN MILLION)
FIGURE 17 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, 2020
FIGURE 18 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, 2019-2028 (USD MILLION)
FIGURE 19 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, CAGR (2021-2028)
FIGURE 20 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 21 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, 2020
FIGURE 22 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, 2019-2028 (USD MILLION)
FIGURE 23 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, CAGR (2021-2028)
FIGURE 24 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, LIFELINE CURVE
FIGURE 25 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, 2020
FIGURE 26 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, 2019-2028 (USD MILLION)
FIGURE 27 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, CAGR (2021-2028)
FIGURE 28 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, LIFELINE CURVE
FIGURE 29 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, 2020
FIGURE 30 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, 2019-2028 (USD MILLION)
FIGURE 31 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, CAGR (2021-2028)
FIGURE 32 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 33 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: SNAPSHOT (2020)
FIGURE 34 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY COUNTRY (2020)
FIGURE 35 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 36 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 37 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT (2021-2028)
FIGURE 38 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET: COMPANY SHARE 2020 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
